Eliminating redundancies, increasing efficiency, and cultivating a culture of collaboration were the main themes of a January 19 webinar featuring top U.S. Food and Drug Administration (FDA) officials, hosted by Alliance for a Stronger FDA to discuss the agency’s proposed reorganization.
The webinar was moderated by Alliance board members Sarah Sorsher, J.D., M.P.H., Director for Regulatory Affairs at Center for Science in the Public Interest (CSPI); and John Taylor, J.D., President and Principal of Compliance and Regulatory Affairs, at Greenleaf Health and former Acting Deputy Commissioner for Global Regulatory Operations and Policy at FDA, as well as a member of the Reagan-Udall Foundation expert panel that conducted the 2022 independent evaluation of FDA.